BUPROPION HCL ER
- Product NDC
- 61919-674
- 11-digit product format
- 619190674
- Labeler code
- 61919
- Product ID
- 61919-674_8e837d14-94d4-1ef9-e053-2995a90a7707
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- BUPROPION HCL ER
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Direct_Rx
- Application
- ANDA207224
- Marketing category
- ANDA
- Marketing start
- 2019-07-25
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 61919-674-30 | BUPROPION HCL ERXL | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 61919-674 | BUPROPION HCL ER XL (BUPROPION HCL ER) TABLET, EXTENDED RELEASE [DIRECT_RX] | 1 | Legacy NDC, 1 package rows | 20190909_8e837d14-94d3-1ef9-e053-2995a90a7707.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61919-674-30 | 61919067430 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (61919-674-30) | 2019-07-25 | 0000-00-00 | No | No | Current |